Go Pro

Cooper Companies (COO) Competitors

Cooper Companies logo
$53.91 -0.26 (-0.48%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$53.93 +0.02 (+0.04%)
As of 09/11/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

COO vs. ALC, MDLN, WST, SOLV, and ALGN

Should you buy Cooper Companies stock or one of its competitors? Cooper Companies's main competitors and comparable companies include Alcon (ALC), Medline (MDLN), West Pharmaceutical Services (WST), Solventum (SOLV), and Align Technology (ALGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Cooper Companies compare to Alcon?

Alcon (NYSE:ALC) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

Alcon has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

In the previous week, Cooper Companies had 79 more articles in the media than Alcon. MarketBeat recorded 81 mentions for Cooper Companies and 2 mentions for Alcon. Cooper Companies' average media sentiment score of 0.22 beat Alcon's score of 0.17 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alcon
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cooper Companies
19 Very Positive mention(s)
7 Positive mention(s)
20 Neutral mention(s)
18 Negative mention(s)
6 Very Negative mention(s)
Neutral

Cooper Companies has a net margin of 13.46% compared to Alcon's net margin of 5.92%. Cooper Companies' return on equity of 10.90% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
Alcon5.92% 7.29% 5.09%
Cooper Companies 13.46%10.90%7.24%

Alcon presently has a consensus target price of $84.96, indicating a potential upside of 28.60%. Cooper Companies has a consensus target price of $71.47, indicating a potential upside of 32.57%. Given Cooper Companies' higher probable upside, analysts plainly believe Cooper Companies is more favorable than Alcon.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alcon
1 Sell rating(s)
6 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.61
Cooper Companies
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17

53.9% of Alcon shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Alcon has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcon$10.40B3.14$980M$1.3150.43
Cooper Companies$4.09B2.50$374.90M$2.9318.40

Summary

Alcon beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Medline?

Cooper Companies (NASDAQ:COO) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Cooper Companies presently has a consensus target price of $71.47, suggesting a potential upside of 32.57%. Medline has a consensus target price of $47.42, suggesting a potential upside of 45.78%. Given Medline's stronger consensus rating and higher possible upside, analysts clearly believe Medline is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17
Medline
1 Sell rating(s)
5 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.83

In the previous week, Cooper Companies had 69 more articles in the media than Medline. MarketBeat recorded 81 mentions for Cooper Companies and 12 mentions for Medline. Medline's average media sentiment score of 1.17 beat Cooper Companies' score of 0.22 indicating that Medline is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
19 Very Positive mention(s)
7 Positive mention(s)
20 Neutral mention(s)
18 Negative mention(s)
6 Very Negative mention(s)
Neutral
Medline
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Cooper Companies has a net margin of 13.46% compared to Medline's net margin of 0.00%. Cooper Companies' return on equity of 10.90% beat Medline's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Medline N/A N/A N/A

Medline has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.50$374.90M$2.9318.40
Medline$28.43B1.50$1.16B$0.7941.18

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.8% of Medline shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cooper Companies and Medline tied by winning 8 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, risk, profitability, valuation and earnings.

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Cooper Companies had 65 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 81 mentions for Cooper Companies and 16 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.06 beat Cooper Companies' score of 0.22 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
10 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
19 Very Positive mention(s)
7 Positive mention(s)
20 Neutral mention(s)
18 Negative mention(s)
6 Very Negative mention(s)
Neutral

West Pharmaceutical Services has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

West Pharmaceutical Services has a net margin of 16.98% compared to Cooper Companies' net margin of 13.46%. West Pharmaceutical Services' return on equity of 20.11% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.98% 20.11% 14.83%
Cooper Companies 13.46%10.90%7.24%

West Pharmaceutical Services presently has a consensus price target of $373.85, indicating a potential upside of 8.21%. Cooper Companies has a consensus price target of $71.47, indicating a potential upside of 32.57%. Given Cooper Companies' higher probable upside, analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87
Cooper Companies
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B7.91$493.70M$7.8144.24
Cooper Companies$4.09B2.50$374.90M$2.9318.40

Summary

West Pharmaceutical Services beats Cooper Companies on 13 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Solventum?

Solventum (NYSE:SOLV) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

Solventum currently has a consensus price target of $92.80, indicating a potential upside of 6.15%. Cooper Companies has a consensus price target of $71.47, indicating a potential upside of 32.57%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.58
Cooper Companies
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17

In the previous week, Cooper Companies had 73 more articles in the media than Solventum. MarketBeat recorded 81 mentions for Cooper Companies and 8 mentions for Solventum. Solventum's average media sentiment score of 1.13 beat Cooper Companies' score of 0.22 indicating that Solventum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
19 Very Positive mention(s)
7 Positive mention(s)
20 Neutral mention(s)
18 Negative mention(s)
6 Very Negative mention(s)
Neutral

Solventum has a net margin of 17.26% compared to Cooper Companies' net margin of 13.46%. Solventum's return on equity of 25.09% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Solventum17.26% 25.09% 8.78%
Cooper Companies 13.46%10.90%7.24%

Solventum has higher revenue and earnings than Cooper Companies. Solventum is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.33B1.79$1.56B$8.1810.69
Cooper Companies$4.09B2.50$374.90M$2.9318.40

Solventum has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

24.4% of Cooper Companies shares are owned by institutional investors. 0.2% of Solventum shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Solventum beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Cooper Companies (NASDAQ:COO) and Align Technology (NASDAQ:ALGN) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

Cooper Companies presently has a consensus price target of $71.47, indicating a potential upside of 32.57%. Align Technology has a consensus price target of $206.36, indicating a potential upside of 36.82%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
2 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.17
Align Technology
0 Sell rating(s)
6 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.67

In the previous week, Cooper Companies had 67 more articles in the media than Align Technology. MarketBeat recorded 81 mentions for Cooper Companies and 14 mentions for Align Technology. Align Technology's average media sentiment score of 1.31 beat Cooper Companies' score of 0.22 indicating that Align Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
19 Very Positive mention(s)
7 Positive mention(s)
20 Neutral mention(s)
18 Negative mention(s)
6 Very Negative mention(s)
Neutral
Align Technology
11 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Align Technology has lower revenue, but higher earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B2.50$374.90M$2.9318.40
Align Technology$4.03B2.68$410.35M$5.7526.23

Cooper Companies has a beta of 0.82, suggesting that its stock price is 18% less volatile than the broader market. Comparatively, Align Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market.

Cooper Companies has a net margin of 13.46% compared to Align Technology's net margin of 9.99%. Align Technology's return on equity of 15.86% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies13.46% 10.90% 7.24%
Align Technology 9.99%15.86%10.32%

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 88.4% of Align Technology shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 0.8% of Align Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Align Technology beats Cooper Companies on 13 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$10.25B$5.48B$7.16B$12.85B
Dividend YieldN/A1.80%2.57%11.71%
P/E Ratio18.4025.09274.9425.33
Price / Sales2.5071.56633.8090.72
Price / Cash8.9033.0328.4234.96
Price / Book1.305.9710.336.21
Net Income$374.90M$150.75M$3.50B$358.54M
7 Day Performance-22.53%-2.83%-3.32%-2.35%
1 Month Performance-29.62%-3.73%-0.53%-3.23%
1 Year Performance-19.15%9.38%23.51%8.79%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.5963 of 5 stars
$53.91
-0.5%
$71.47
+32.6%
-19.2%$10.25B$4.09B18.4015,000
ALC
Alcon
3.2817 of 5 stars
$70.89
-1.6%
$84.96
+19.8%
-15.6%$35.03B$10.40B54.0725,942
MDLN
Medline
3.9354 of 5 stars
$36.56
-0.1%
$47.42
+29.7%
N/A$48.06B$28.43B46.2745,000
WST
West Pharmaceutical Services
3.6846 of 5 stars
$341.64
-0.3%
$368.08
+7.7%
+36.3%$24.04B$3.07B43.7410,800
SOLV
Solventum
1.9681 of 5 stars
$91.60
-0.9%
$91.64
+0.0%
+19.2%$15.58B$8.33B11.1920,000

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners